These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25012099)

  • 1. E/A ratio before cardiac resynchronization therapy predicts left ventricle reverse remodeling.
    Iori M; Bottoni N; Quartieri F; Manari A
    Minerva Cardioangiol; 2014 Aug; 62(4):305-9. PubMed ID: 25012099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy.
    Kydd AC; Khan FZ; Ring L; Pugh PJ; Virdee MS; Dutka DP
    Eur J Heart Fail; 2014 Nov; 16(11):1206-13. PubMed ID: 25302484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
    Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
    Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic variables predictive of appropriate therapies for ventricular tachyarrhythmia in patients undergoing combined cardiac resynchronization therapy.
    Timóteo AT; Galrinho A; Branco LM; Oliveira MM; da Silva MN; Feliciano J; Soares R; Cunha PS; Leal A; Santos S; Ferreira RC
    Rev Port Cardiol; 2010 Jun; 29(6):1009-19. PubMed ID: 20964112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.
    Brunet-Bernard A; Maréchaux S; Fauchier L; Guiot A; Fournet M; Reynaud A; Schnell F; Leclercq C; Mabo P; Donal E
    Am J Cardiol; 2014 Jun; 113(12):2045-51. PubMed ID: 24793667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
    Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using three-dimensional echocardiography to guide left ventricle lead position in cardiac resynchronization therapy: does it make any difference.
    Badran HA; Kamel JZ; Mohamed TR; Abdelhamid MA
    J Interv Card Electrophysiol; 2017 Apr; 48(3):299-306. PubMed ID: 28194611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Cardiac Resynchronization Therapy on Ventricular Electrical Remodeling in Patients With Heart Failure.
    Zhang J; Xing Q; Zhou X; Zhang Y; Li Y; Li J; Tang B
    Int Heart J; 2015; 56(5):495-9. PubMed ID: 26370368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
    Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.